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Despite recent advances unraveling mechanisms of hostepathogen interactions in innate
immunity, the participation of purinergic signaling in infection-driven inflammation re-
mains an emerging research field with many unanswered questions. As one of the most-
studied oral pathogens, Porphyromonas gingivalis is considered as a keystone pathogen
with a central role in development of periodontal disease. This pathogen needs to evade
immune-mediated defense mechanisms and tolerate inflammation in order to survive in
the host. In this review, we summarize evidence showing that purinergic signaling mod-
ulates P. gingivalis survival and cellular immune responses, and discuss the role played by
inflammasome activation and cell death during P. gingivalis infection.Innate immunity and oral microbes
The host organism is always ready to respond to foreign
stimuli, such as infection by pathogens. The first response of
the host immune system is carried out by innate immunity.
Unlike the adaptive response (which includes specific anti-
bodies and lymphocytes), the repertoire of the innateof the Federal Universit
Fund~ao, Rio de Janeiro, R
utinho-Silva).
g Gung University.
n this work.
ublishing services by Else
s/by-nc-nd/4.0/).response is common among all normal and healthy in-
dividuals. This response involves cellular and humoral activ-
ities, as well as chemical (e.g. acidic stomach pH, saliva and
tears) and anatomical barriers (e.g. epithelial cells throughout
the body).
Cellular responses to pathogens depend on the recognition
of evolutionarily conserved structures that are typicallyy of Rio de Janeiro, Health Sciences Center, G. Block, Av. Carlos
J 21941-902, Brazil. Tel.: +55 21 3938 6565; fax: +55 21 2281 8193.
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called “Pathogens AssociatedMolecular Patterns” (PAMPs), are
recognized by innate immune cells by “Pattern Recognition
Receptors” (PRRs). PRRs include Toll-like receptors (TLRs),
nucleotide-binding and oligomerization domain (NOD)-like
receptors (NLRs), retinoic-acid-inducible gene I (RIG-I)-like
receptors (RLRs), and the C-type lectin receptors (CLRs), as
well as DNA receptors (cytosolic sensors for DNA) [1e3].
Different PAMPs can be recognized by PRRs, whose ligation
leads to activation of transcription factors, such as activator
protein 1 (AP-1) and nuclear factor kappa B (NF-kB), which in
turn, modulate gene transcription of pro-inflammatory cyto-
kines and chemokines [4]. This response is important for the
host to control infections and prevent disease.
Knowledge about the human microbiota and its rela-
tionship with the host is also crucial for better understand-
ing the mechanisms of immunity, since the microbiota can
stimulate and modulate the immune system. The human
body contains 10 times more prokaryotic than eukaryotic
cells, and humans and microbes have evolved to gradually
become dependent on one another [5]. The oral mucosa is
associated with hundreds of different viruses and bacterial,
archaeal, fungal, and protozoan species, many of which can
interact to form biofilms conferring resistance to the mi-
croorganisms against mechanical and chemical stress [5,6].
In this context, bacterial communities found in the oral
mucosa are highly complex (comprising around 1000 spe-
cies) and are one of the most complex in the whole body [6].
Most of the oral microbes live as commensals within the
host, but some species can become pathogenic in response
to the host genotype, stress, diet or behavior (e.g. smoking)
[7].
Not surprisingly, some oral microbes have been related to
oral disorders, including periodontal disease (or periodontitis),
which is commonly manifested as a chronic and inflamma-
tory condition induced by biofilms and pathogens closely
associated with the periodontium (the structures that protect
and support teeth, such as gingiva, periodontal ligament and
alveolar bone). When the periodontium is damaged, a process
of uncontrolled bone resorption is initiated and can lead to
tooth loss as a consequence [7,8]. Socransky and colleagues
identified several bacteria present in subgingival biofilms
from individuals with periodontitis and grouped these bacte-
ria in complexes according to their association with disease
[9]. Among these complexes, the onemost strongly associated
with periodontitis is the so-called “red complex” bacteria. The
“red complex” consists of Tannerela forsythia, Treponema denti-
cola and Porphyromonas gingivalis, which are related to human
periodontitis because of their strong association with the
diseased sites [9,10].
P. gingivalis is an anaerobic, asaccharolytic, black-
pigmented, non-motile and non-spore forming Gram-
negative bacterium, which exists as different strains with
variable virulence [11e13]. P. gingivalis is mainly found during
diseased states but it can be also found in healthy individuals,
with a prevalence that ranges around 25% in healthy in-
dividuals and 79% in individuals with periodontitis [14].
Recent studies have suggested a new paradigm of periodontal
pathogenesis, which assigns a larger role for some bacteria
from the oral microbiota and host susceptibility indevelopment of disease. Usually, pathogenic bacteria lead to
inflammation by direct infection and dysregulation of the
commensal microbiota. P. gingivalis was described as a
“keystone pathogen” due to its ability to induce dysbiosis and
inflammation even in relatively low numbers. Using a murine
model of experimental periodontitis, it was shown that, even
in low-abundance after inoculation, P. gingivalis can infect the
oral mucosa and promote changes in numbers and composi-
tion of the oral commensal microbiota, leading to a dysbiotic
environment [15]. Dysbiosis is characterized by an imbalance
in the relative abundance of species within the microbiota
that is related to disease induction [7]. This study also showed
that P. gingivalis inoculation in the oral cavity led to bone loss
in specific pathogen free (SPF) mice, but P. gingivalis alone
could infect but did not induce bone loss in germ-free mice.
These data resulted in the “keystone pathogen hypothesis” of
periodontal disease [15].
Besides being considered a keystone pathogen, this bac-
terium is also associated with increased risk of diverse sys-
temic diseases. Oral health is important for overall health
since it has been shown that periodontitis increases the pa-
tients' risk for atherosclerosis, rheumatoid arthritis, and
cancer [16e20]. In fact, during periodontal disease, bacteria
reach blood vessels temporarily and this transient bacteremia
is responsible for spreading bacteria to different sites of the
organism, such as atherosclerotic plaques (as detected by PCR
[17]), where they can accelerate pathogenesis.
P. gingivalis has evolved several virulence factors to evade
innate and adaptive immunity and cause disease. There is a
large body of evidence describing the ambivalent behavior of
this microorganism, which on one hand needs to escape
immune-mediated detection and on the other hand tolerates
and perpetuates inflammation to survive in the host. It was
shown that P. gingivalis fimbriae can highly activate human
monocytes and poorly activate epithelial cells with regards to
interleukin (IL)-6, IL-8, macrophage colony stimulating factor
(M-CSF) and tumor necrosis factor (TNF)-a responses, thus
reflecting different strategies used by this bacterium when
interacting with distinct host cell types [21]. As another
example, P. gingivalis can manipulate host neutrophils
through complement C5a receptor and TLR2 pathways in a
cooperative crosstalk involving downstream adaptor mole-
cules such as MyD88 [22]. This study showed higher bacterial
survival in infected MyD88-deficient mice compared with
wild-type mice. In vitro, MyD88-depleted human periodontal
fibroblasts showed decreased expression of major inflamma-
tory cytokines such as IL-6 and IL-8 compared to control cells
when stimulated with P. gingivalis LPS [23]. Moreover, cysteine
proteinases called gingipains from P. gingivalis can influence
the composition of polymicrobial biofilms [24]. This work
revealed an interdependency between the gingipains of P.
gingivalis and T. forsythia or T. denticola, thus suggesting sup-
ported survival and virulence of the biofilm community as a
whole. The capacity of P. gingivalis to interact with other
periodontal pathogens such as Fusobacterium nucleatum was
also demonstrated in the case of P. gingivalis' ability to sup-
press inflammasome activity [25], which will be discussed
later in this review. Finally, P. gingivalis expresses hemagluti-
nins, as well as an atypical and less immunogenic LPS, which
can be an antagonist of TLR4 ligation; a serine phosphatase B
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(GECs); fimbriae that are involved in bacterial adhesion; and a
nucleoside-diphosphate-kinase (NDK), which hydrolyzes
extracellular ATP (eATP) and will be discussed in more detail
later in this review.
P. gingivalis can also evade different mechanisms of adap-
tive immunity. Human neutrophils, peripheral blood mono-
nuclear cells (PBMCs) and GECs infected with P. gingivalis
produced IL-1b but not the T-cell chemokine CXCL10 [26]. Thus,
P. gingivalis infection inhibited interferon (IFN)-g-induced and
F. nucleatum-induced CXCL10 secretion by epithelial cells.
Moreover, P. gingivalis adhesion induced morphological
changes, reactive-oxygen-species (ROS) production and
increased intracellular Caþ2 levels in T-cells [27]. This peri-
odontal pathogen also inhibited AP-1 and NF-kB activity, as
well as IL-2 accumulation, by means of its gingipains. Another
study demonstrated that gingipains of P. gingivalis cleave
immunoglobulin G1 (IgG1) in gingival crevicular fluid of pa-
tients and may suppress antibody-dependent antibacterial
activity in vivo [28]. Also, it was shown that, upon initial
encounter with P. gingivalis in vivo, murine splenic T cells and
CD11bþ cells produced IL-10, and this cytokine suppressed IFN-
g T cell responses [29]. Furthermore, it was demonstrated that
supernatants of human immune cells infected with two
different strains of P. gingivalis-induced T helper cell polariza-
tion to a Th17 profile instead of a Th1 profile [30]. Moreover, P.
gingivalis favored the generation of Th17-related cytokines
such as IL-1b, IL-6 and IL-23 but not the Th1-related cytokine,
IL-12. Interestingly, another laboratory showed that subcu-
taneous vaccination with formalin-killed P. gingivalis protected
the mice from alveolar bone resorption and inflammation by
downregulation of Th17 cells and IL-17A production, while
promoting upregulation of regulatory T (Treg) cells, IL-10 and
transforming growth factor-b1 (TGF-b1) [31].Purinergic signaling in the context of infection
and inflammation
ATP is traditionally associated with cellular energy meta-
bolism in all prokaryotic and eukaryotic cell types, but it is
also recognized that ATP and other nucleotides are released
from cells following stress or injury [32,33]. It has been shown
that controlled and uncontrolled mechanisms of ATP release
to the extracellular space takes place during cellular stress,
death or tissue injury. It has been demonstrated thus far that
ATP is released from necrotic cells via pannexin channels,
connexin hemichannels and also via the P2X7 receptor [34,35].
In the extracellular compartment, nucleotides can be recog-
nized by the host immune system as danger signals and can
promote several biological activities in different immune cell
types. Examples include: maturation of immature dendritic
cells, secretion of pro-inflammatory cytokines by macro-
phages, chemotaxis and IL-8 production by eosinophils, and
costimulation for antigenic stimulation by T and B cells
[35,36]. These molecules bind to purinergic receptors
expressed on virtually all immune cell types [33].
Purinergic receptors are divided into two families: P1 and
P2 receptors [32]. The G-protein coupled metabotropic P1 re-
ceptors recognize exclusively adenosine and can besubdivided into A1, A2A, A2B and A3 receptors, all of whichwith
different binding affinities for adenosine [32,37]. The receptors
A1 and A3 are coupled to protein Gi, and A2A and A2B becoming
associated with protein Gs [37,38]. The P2 receptors can be
subdivided into two subtypes: non-selective ion-gated chan-
nel P2X receptors (that recognize ATP) and G-coupled P2Y re-
ceptors (that recognize ATP, ADP, UTP, UDP and UDP-glucose)
[35,36]. To date, seven P2X receptors (from P2X1 to P2X7) with
different affinities for ATP have been described. Among these
receptors, the P2X7 receptor has a low affinity for ATP
(requiring 100 mM to be activated; while others can be acti-
vated at lower concentrations) and has been associated with
immune responses and inflammation, such as inhibition of
infection by intracellular pathogens and activation of the
inflammasome, which will be discussed later in this review
[4,39e41,41].
ATP ligation of the P2X7 receptor leads to opening of a
transmembrane non-selective cationic channel that allows Kþ
efflux and Naþ and Ca2þ influx and promotes cytoplasmic
membrane depolarization [35]. P2X7 receptor activation is
associated with pore formation, which depends on the con-
centration and duration of ATP treatment [41]. Continuous
stimulation of the P2X7 receptor with ATP can induce cell
death either by necrosis or apoptosis [42], as well as lead to
opening of a pore that allows the passage of molecules up to
900 Da [43].
Since recognition of high levels of eATP results in modu-
lation of immune responses, the host has a sophisticated and
sensitive mechanism to regulate the composition, duration,
intensity and magnitude of purinergic signaling, as reviewed
elsewhere [41]. Immune and non-immune cells utilize a group
of nucleotide-hydrolyzing enzymes called ecto-nucleotidases
to control exacerbated levels of nucleotides and maintain
steady-state conditions. The ecto-nucleoside triphosphate
diphosphohydrolases (E-NTPDases which degrade extracel-
lular tri- and diphosphonucleosides to monophosphonucleo-
sides), ecto-nucleotide pyrophosphatase/phosphodiesterases
(E-NPPs that hydrolyze pyrophosphate and phosphodiester
bonds in a wide range of substrates), and ecto-50-nucleotidase
(which degrades AMP) are the most relevant ecto-nucleotid-
ases in the context of innate immunity [41]. These enzymes
are responsible for maintaining healthy and stable levels of
eATP [36] and generating adenosine, a metabolite of ATP
breakdown [41].
While ATP exhibits pro-inflammatory and stimulatory ef-
fects in the immune system and physiology [35,44e51],
adenosine has primarily anti-inflammatory and inhibitory
effects [37,52e56]. Therefore, the balance between ATP versus
adenosine levels is important in modulating cellular immune
responses and pathogen survival [Fig. 1].ATP effects in intracellular pathogen infection
Immune and epithelial cells activate microbicidal pathways
and contribute to inflammation after ligation of purinergic P2
receptors by eATP [Fig. 1]. Facultative and obligate intracel-
lular microbes survive inside the host cell, where they acquire
nutrients needed for microbial replication and propagation of
the infection [53,57]. For intracellular pathogens, it is
Fig. 1 e Schematic figure of the antagonistic effects of P1 and P2 receptors on infected cells. On the left, extracellular adenosine
is recognized by P1 receptors (for example, A2A and A2B) and can promote pathogen survival or reversibly retard microbial
growth. On the other hand, on the right, eATP released from stressed, dying or infected cells binds to P2 receptors (for example,
P2X7) and leads to pathogen elimination through several pathways: (1) host cell death; (2) inflammasome activation and IL-1b
secretion; (3) ROS and NO production; (4) or phospholipase D activation, promoting lysosome and phagosome fusion.
Importantly, ecto-nucleotidases (E-NTPDases) from several pathogens inhibit pathogen elimination by eATP cleavage and/or
favor microbial survival by generating extracellular adenosine.
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host cell in order to promote survival and growth of the
pathogen. In this regard, several pathogens evolved different
mechanisms to promote their own growth inside the host cell,
as for example Mycobacterium tuberculosis, Chlamydia tracho-
matis, Leishmania species, Toxoplasma gondii and also P.
gingivalis.
Unlike activation of surface CD95 (Fas receptor), leading to
host cell apoptosis, or complement-mediated host cell lysis,
which do not inducemycobacterial death [50], eATP treatment
of macrophages enhances their antimicrobial properties in a
P2X7 receptor-dependent manner. We and others showed
that eATP-related killing of M. tuberculosis and C. trachomatis
within human and murine macrophages is mediated by
phospholipase D, which is associated with mobilization of
intracellular Caþ2 and consequently lysosomal fusion and
acidification of the phagosomes containing the pathogen
[44,48,49]. In another study, it was shown that adenine nu-
cleotides (adenosine, AMP and ATP) can inhibit C. trachomatis
growth in epithelial cells [58]. Moreover, millimolar eATP
concentrations inhibit chlamydial infection via P2X7 receptor
in macrophages [48], while micromolar eATP concentrations
reversibly inhibit chlamydial infection via the P2X4 receptor in
epithelial cells [58].
Infection with the protozoan parasite Leishmania
amazonensis is also controlled by eATP treatment. Murinemacrophages infected with L. amazonensis showed enhanced
P2X7 receptor expression in vitro and were more responsive to
eATP activation in vitro and in vivo, where cells from estab-
lished cutaneous lesions were more sensitive to eATP than
cells from uninfected mice [46]. Additionally, elimination of
Leishmania via eATP ligation of the P2X7 receptor is involved
with leukotriene B4 production in a 5-lipoxigenase
dependent-manner [45,46]. Another work showed that UTP,
but not UDP, inhibits L. amazonensis infection in murine
macrophages, inducing morphological damage in the intra-
cellular parasite, promoting apoptosis of macrophages and
production of oxygen and nitrogen reactive species, and
increasing intracellular Caþ2 concentrations [59]. These ef-
fects are believed to occur via P2Y2 and P2Y4 receptors
following their upregulation during L. amazonensis infection.
Periodate-oxidized ATP also induces morphological changes
directly in the parasite, dampening the attachment and entry
of the protozoa in murine macrophages [60].
Another intracellular protozoan parasite affected by puri-
nergic signaling is T. gondii. eATP treatment in infected mac-
rophages promotes T. gondii elimination via P2X7 receptor
through acidification of the parasitophorous vacuole and ROS
production [47,51]. Additionally, our group recently demon-
strated that UTP and UDP treatment in murine macrophages
infected with T. gondii promotes 90% elimination of the para-
site, without inducing NO, ROS or apoptosis in the host cell
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the host cell via P2Y2, P2Y4 and P2Y6, thus compromising
infectivity and replication of the egressed parasites.
The expression of P2X2, P2X4, P2X5, P2X6 and P2X7 re-
ceptors was also reported in GECs, and eATP, unlike other
extracellular nucleotides such as UTP and ADP, induced
apoptosis of these cells [62]. These studies also demonstrated
that P. gingivalis infection inhibits eATP-induced apoptosis in
GECs through a mechanism that depends on a homolog of
nucleoside-diphosphate-kinase (NDK), which is secreted by P.
gingivalis [62,63]. NDK is an ubiquitous enzyme that is highly
conserved in prokaryotes and eukaryotes, including plants
[64,65]. The main role of NDK is to catalyze the transfer of
terminal phosphate groups from 50-triphosphate- to 50-
diphosphate-nucleotides [64e66]. Thus NDK has the ability to
hydrolyze (and also synthesize) any NTP/dNTP [65,67]. In this
context, the NDK from P. gingivalis can hydrolyze eATP after
infection in human GECs. The enzyme can thus (1) diminish
eATP-induced apoptosis [62]; (2) inhibit eATP-induced ROS via
P2X7/NADPH oxidase signaling [63]; and (3) attenuate eATP-Fig. 2 e Schematic figure of the effects of P1 receptors, P2 recepto
inflammasome activation. (1) As the first signal required for inflam
through TLR2, and (2) reaches the cytosolic compartment. (3) Reco
of the transcriptional factor NF-kB to the nucleus. (4) Once in the
transcription of inflammasome components (5) and promotes pro
which may be released to the extracellular compartment. (7) In a
release from the host cell to the extracellular space. As a second
P2X7 receptor can promote Kþ efflux, ROS generation and/or lyso
inflammasome. The NLRP3 inflammasome activates procaspase-
proteolytically processes pro-IL-1b into IL-1b, (11) which is release
generating its own metabolites, such as ADP, (13) which are recog
as CD39, generating AMP. (14) AMP binds to CD73 on the host cel
interaction via adenosine receptor (16) can promote pro-IL-1b stainduced inflammasome activation, therefore impairing IL-1b
release [68]. In contrast, the presence of NDK from Pseudo-
monas aeruginosa [69] and P. gingivalis during infection in mu-
rine macrophages contributes to pro-IL-1b production/
stability and induces IL-1b secretion [unpublished data e
Fig. 2], thus demonstrating differences in the role of NDK from
P. gingivalis after infection in different cell lines.Adenosine effects on P. gingivalis infection
Adenosine is also considered as a danger signal, which can be
released from stressed, necrotic or dying cells, or can be
generated via dephosphorylation of eATP by the ecto-nucleo-
tidases CD39 and CD73, as reviewed elsewhere [41,70]. In favor
of the role of adenosine in downregulating immune responses
and inflammation [37,52,53,55,56] [Fig. 1], a recent study has
found that agonist of adenosine receptors, when added exog-
enously in vitro, stimulates the growth of P. gingivalis in GECs
[54]. This work demonstrated that GECs express all thers, and ecto-nucleotidases on P. gingivalis-induced
masome activation, P. gingivalis is recognized by the host cell
gnition of the bacterium via TLR2 promotes the translocation
nucleus, NF-kB induces pro-inflammatory cytokines and
-IL-1b synthesis. (6) Concomitantly, P. gingivalis secretes NDK,
ddition, after infection, this oral bacterium induces ATP
signal for inflammasome activation, (8) ATP ligation to the
some damage, (9) which can activate the NLRP3
1 to the mature caspase-1, and (10) this enzyme, in turn,
d from the cell. (12) NDK from P. gingivalis hydrolyzes eATP,
nized and cleaved via ecto-nucleotidases from the host, such
l, and this enzyme can generate adenosine. (15) Adenosine
bility and thus, supports IL-1b secretion.
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CGS21680 specific-agonist could enhance proliferation of P.
gingivalis. On the other hand, a high-affinity adenosine recep-
tor agonist NECA, or adenosine by itself, could reversibly
inhibit growth of the intracellular bacterium C. trachomatis via
A2B receptors [71]. Adenosine is also important in survival of
protozoan parasites, such as the obligate intracellular path-
ogen T. gondii. CD73-generated extracellular adenosine is
important for T. gondii survival because this pathogen can not
to make its own [53]. Thus, CD73-deficient mice infected with
T. gondii have lower parasite levels and are protected from
chronic infection when compared with wild-type mice. Since
mice lacking adenosine receptors have no effect in cyst for-
mation, CD73 expression is thought to promote T. gondii dif-
ferentiation and cyst formation by amechanism dependent on
adenosine generation, but independent of adenosine receptor
signaling [53], suggesting that the parasite utilizes adenosine
as a substrate for its own metabolism. Thus, adenosine effects
on cells infected with intracellular pathogens depends on the
specific type of pathogen andmay depend onwhich adenosine
receptor is stimulated [Fig. 1].
Because of the role of adenosine in facilitating survival of
some microorganisms, some pathogens have evolved mech-
anisms to stimulate extracellular adenosine generation inde-
pendently of the host. Staphylococcus aureus produces
adenosine synthase A (AdsA) as a virulence factor, a cell wall-
anchored enzyme which allows the bacteria to escape from
phagocytic clearance and favoring the formation of organ
abscesses [52]. Moreover, the same study showed that other
prominent bacteria from the oral cavity including Enterococcus
faecalis and Streptococcus mutans possess uncharacterized ho-
mologs of adenosine synthase.
Furthermore, some pathogens have evolved extracellular
nucleotide-hydrolyzing enzymes that mimic the ecto-nucle-
otidases expressed in the host [Fig. 1]. For example, the sur-
face of Trypanosoma cruzi expresses a Mg2þ-dependent ecto-
ATPase activity, whose function is 20 times greater in trypo-
mastigotes than in epimastigotes, suggesting a role for this
enzyme in promoting infection in the vertebrate host [72]. A
comparison of the Mg2þ-ecto-ATPase activities of the three
forms of T. cruzi showed that the noninfective epimastigotes
are less efficient at hydrolyzing eATP than the infective try-
pomastigote and amastigote stages [73]. Another parasitewith
Mg2þ-dependent ecto-ATPase is L. amazonensis, where the
avirulent promastigotes are less efficient than the virulent
promastigotes in hydrolyzing eATP, suggesting that virulent
strains acquire adenosine and utilize it in its favor [74].
Interestingly, some bacteria secrete ATP during their
growth [75], which may play a role in bacterial physiology. In
the oral cavity, it was found that Aggregatibacter actino-
mycetemcomitans but not P. gingivalis, Prevotella intermedia, or F.
nucleatum secrete ATP into the culture supernatant during its
growth [76]. Infection in general can induce release of ATP
from the host cell [77], and P. gingivalis infection stimulates
ATP liberation after infection in GECs [63], THP-1macrophages
[78], and murine macrophages (unpublished data). It is
tempting to speculate that eATP may be secreted during
infection by some pathogens during their growth, such as the
common bacteria Escherichia coli, Staphylococcus, Acinetobacter,
and others; while supporting the survival of other pathogensduring infection e for example during infection by L. ama-
zonensis, T. gondii and T. cruzi, due to their ability to hydrolyze
eATP generating adenosine, which is necessary for their
survival.Inflammasomes and purinergic signaling
associated with P. gingivalis infection
Inflammasomes, discovered in 2002, are multi-protein com-
plexes assembled in the host cell in response to infection or
cellular stress, leading to a type of cell death called pyroptosis
and/or maturation and secretion of pro-inflammatory cyto-
kines, such as IL-1b and IL-18 [79e81]. Pyroptosis is a non-
homeostatic and lytic cell death dependent on caspase-1
and/or caspase-11 activation [80,82,82]. P2X7 receptor was
shown to activate NLRP3 inflammasomes [83]; and recently,
caspase-11-induced pyroptosis was shown to require
pannexin-1 channels and the P2X7 receptor [84]. This kind of
cell death presents similarities to necrosis such as an increase
in the cytoplasmic volume and rupture of the cellular plasma
membrane. In the context of inflammasome activation, pro-
inflammatory cytokines are important for eliminating patho-
gens [4,82]. Pyroptosis is important because of the cytokines,
chemokines and DAMPs which are released to the extracel-
lular compartment, and also because this type of cell death
exposes intracellular bacteria to extracellular immune sur-
veillance, thus allowing their destruction by antimicrobial
peptides, immunoglobulins, and the complement system, and
their uptake by immune cells [79]. IL-1b affects virtually all
cells and organs of the body and is one of the most important
cytokines that mediate autoimmunity, infections and degen-
erative diseases [85]. This cytokine has a role in the central
nervous system as an endogenous pyrogenic agent, and it can
also induce inflammation, leukocyte recruitment, and Th17
profile immune responses [85,86]. Inflammasomes are usually
studied in immune cells, but they can also be activated in
several types of epithelial cells, including GECs [87].
Canonical inflammasomes convert procaspase-1 into the
catalytically active enzyme, caspase-1, whereas a still
completely undefined non-canonical inflammasome pro-
motes activation of procaspase-11 [82,88]. Several canonical
inflammasome complexes have been identified depending on
the receptor that recognizes the PAMPs (for example, NLRP1,
NLRP3, AIM2, NLRC4), while the non-canonical inflammasome
can be activated by cytosolic LPS derived from Gram-negative
bacteria. One of the best characterized inflammasomes con-
tains the NLRmember, NLRP3, the adaptor protein, apoptosis-
associated speck-like protein containing a CARD (ASC), and
the protease, caspase-1. The NLRP3 inflammasome can be
activated by different stimuli, such as bacterial, viral, and
fungal pathogens, pore-forming toxins, crystals, silica and
DAMPs (for example, eATP) [82,89]. The activation of the ca-
nonical NLRP3 inflammasome typically requires two signals:
(1) a PAMP, such as LPS, leading to transcription of NF-kB,
upregulating genes encoding pro-inflammatory cytokines,
chemokines and proteins involved in the inflammasome
platform; and (2) a DAMP, such as eATP, which induces
inflammasome activation after ligation to the P2X7 receptor
[39]. Once activated, these complexes promote activation of
b i om e d i c a l j o u r n a l 3 9 ( 2 0 1 6 ) 2 5 1e2 6 0 257the protease caspase-1, which cleaves pro-IL-1b and pro-IL-18
into their active forms: IL-1b and IL-18.
As reviewed elsewhere [79], inflammasome activation oc-
curs in response to microbial invasion and is important for
controlling infections. The murine NLRP1 inflammasome
recognizes the cytosolic Bacillus anthracis lethal toxin, and
mutations in the Nlrp1b gene confer susceptibility to anthrax
lethal toxin-induced macrophage death. A defective NLPR3
inflammasome leads to mice susceptibility to Candida albicans
and Aspergillus fumigatus infections [79]. Besides stimulating
secretion of IL-1b and IL-18, the induction of pyroptosis is a
critical in vivomechanism bywhich the NLRC4 inflammasome
clears flagellin-expressing bacteria, such as Legionella pneu-
mophila and Burkholderia thailandensis. Moreover, Francisella
tularensis activates the AIM2 inflammasome, as shown by the
increased susceptibility of caspase-1-deficient mice to infec-
tion with this pathogen [79].
IL-1b regulates innate immune responses and is critical for
host defense against bacterial infection. However, excessive IL-
1b production or inflammasome components [78], as well as
increased P2X7 receptor and NLRP3 mRNA levels [90,91], are
linked to periodontal disease in human gingival tissues.
Recently, ourgroupdemonstrated that inmurinemacrophages,
eATP-induced IL-1b secretion is impaired by P. gingivalis
fimbriae in a P2X7-dependent manner [92]. In human macro-
phages, P. gingivalis induces IL-1b secretion and inflammatory
cell death via caspase-1 activation (pyroptosis). Moreover, IL-1b
secretion and pyroptotic cell death requires both NLRP3 and
AIM2 inflammasome activation by this oral pathogen. P. gingi-
valis infection inducesATP release frommacrophages,which is
mediated byNLRP3 inflammasomeactivationvia P2X7 receptor
stimulation and lysosomal damage [78]. In addition, GECs ex-
press the inflammasome components, NLRP3, NLRC4 and
NLRP1 [93]. P. gingivalis stimulated expression of IL-1b mRNA
and intracellular accumulation of pro-IL-1b, although IL-1b
secretion required on the addition of eATP in vitro. In GECs,
eATP, but not P. gingivalis alone, induced caspase-1 activation
[93]. Thus, P. gingivalis infection can provide the signals neces-
sary for synthesis of pro-IL-1b, but an exogenous danger signal,
such as eATP, must activate the inflammasome, allowing the
infected cell to secrete mature IL-1b.
eATP induces ROS production through a complex consist-
ing of the P2X4, P2X7 receptor and pannexin-1, and the P2X7-
mediated ROS production can activate the NLRP3 inflamma-
some and caspase-1 [94]. Interestingly, P. gingivalis infection in
GECs induces partially reduction of NLRP3 mRNA levels
compared with uninfected GECs [93], suggesting that P. gingi-
valis can inhibit inflammasome components to promote its
own survival. Consistent with the idea that P. gingivalis sup-
presses immune responses, P. gingivalis also suppresses
inflammasome activation due to infection by another oral
bacterium, F. nucleatum. This repression affects IL-1b and IL-18
processing and cell death, in both human and murine mac-
rophages. F. nucleatum activates IL-1b secretion via the NLRP3
inflammasome, but when macrophages are co-infected with
F. nucleatum and P. gingivalis, activation of the inflammasome
and caspase-1, as well as IL-1b secretion, are inhibited by P.
gingivalis [25]. Since inflammasome activation is important for
controlling infection, and P. gingivalis-induced inflammasome
activation is linked to induction of periodontitis, it is stillunclear if deficiencies in inflammasome activation could favor
P. gingivalis infection or, instead, impair periodontitis and
alveolar bone loss induced by this periodontal pathogen.Concluding remarks
Purinergic signaling can up- or down-modulate immune re-
sponses depending on the danger signals present, the puri-
nergic receptor that is activated, and the cell type involved in
the process [Fig. 1]. A large body of evidence demonstrates
that purinergic signaling affects clearance or persistence of
infection by P. gingivalis and others pathogens. P1 as well as P2
receptors modulate P. gingivalis infection as a function of the
danger signal involved. Moreover, ecto-enzymes from the
host cell or from the pathogens can modulate the course of
infection by influencing the availability of nucleotides in the
microenvironment. Finally, P2X7 receptor is involved in the
activation of inflammasomes and its activation can control
different infections. Because of the purinergic signaling can
modulate different intracellular infections including those
with the oral pathogen P. gingivalis, this field represents an
important focus for future research regarding survival and
elimination of different pathogens.Conflicts of interest
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